LoginGet started
Picture of Legend Biotech logo

LEGN — Legend Biotech Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Legend Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-130-308-386-446-520
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-2.618632.125.1132
Unusual Items
Other Non-Cash Items
Changes in Working Capital45.9-11.2142201-25.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-83.1-223-198-201-393
Capital Expenditures-39.2-49.8-47.1-22.3-22.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-19.525.6-148-54.8116
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-58.7-24.2-195-77.192.8
Financing Cash Flow Items—-2.5100—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14.7619627378791
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-12737223397.1492